GlassScriptPhysician profile
Trevor Hansen
NPI 1821450610
$4,141.90
in general payments reported to CMS, 2019-2025
29 companies · $1,089 in 2025
The $1,089 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,009 · 2024: $1,044 · 2025: $1,089.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,157 · Travel and Lodging: $985.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,156.76 |
| Travel and Lodging | $985.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trimed, INC. | $1,850.71 | 2023 | |
| Musculoskeletal Transplant Foundation INC. | $394.65 | 2024-2025 | |
| Tela Bio, INC. | $221.96 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Merck Sharp & Dohme LLC | $180.08 | 2024-2025 | Keytruda, Lynparza |
| Davol INC. | $174.87 | 2025 | Arista |
| Mentor Worldwide LLC | $148.44 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Zimmer Biomet Holdings, INC. | $144.94 | 2024 | Dvr Anatomic Kickstand, A.L.P.S. |
| Polynovo North America LLC | $130.50 | 2025 | Novosorb Btm |
| Organogenesis INC. | $125.83 | 2025 | Puraply Wound Matrix, Simplimax, Via Matrix |
| Endo Pharmaceuticals INC. | $99.88 | 2023 | Xiaflex |
| Abbvie INC. | $86.12 | 2024-2025 | |
| Accord Healthcare, INC. | $81.96 | 2023-2024 | |
| Dendreon Pharmaceuticals LLC | $76.75 | 2024-2025 | Provenge |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.73 | 2024 | Spevigo |
| Olympus America INC. | $44.51 | 2023-2025 | Itind System, Bovie |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $42.55 | 2024-2025 | Irrisept |
| Kerecis Limited | $32.62 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Sumitomo Pharma America, INC. | $25.70 | 2024 | Orgovyx |
| Progenics Pharmaceuticals, INC. | $24.86 | 2024 | |
| Teleflex LLC | $23.87 | 2025 | Urolift |
| Acera Surgical, INC. | $23.39 | 2024 | Restrata Wound Matrix |
| Valencia Technologies Corporation | $21.49 | 2025 | Ecoin Device Kit |
| Boston Scientific Corporation | $21.06 | 2025 | Axonics |
| Alnylam Pharmaceuticals INC. | $18.17 | 2025 | Givlaari |
| Janssen Biotech, INC. | $17.63 | 2025 | Erleada, Akeega |
| Integra Lifesciences Corporation | $16.95 | 2024 | Integra, Surgimend, Omnigraft |
| Calyxo, INC. | $16.69 | 2024 | Cvac Aspiration System |
| Endo USA, INC. | $16.11 | 2025 | Xiaflex, Aveed |
| Kowa Pharmaceuticals America, INC. | $12.88 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trevor Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.